Transplant Report

Annual accrual by region


Australasian Bone Marrow Transplant Recipient Registry (ABMTRR)

ABMTRR Report for HCC 2014

Haemopoietic stem cell transplants (HSCT) are used to treat a range of both haematological and non-haematological malignancies and other serious blood conditions. These stem cells may come from bone marrow, peripheral blood or cord blood. Transplants can be allogeneic, where a donor supplies stem cells from marrow or blood, or autologous, where the patient's own stem cells are harvested and then returned after high-dose conditioning chemotherapy. HSCT are used as treatment for many indications including acute and chronic leukaemias, lymphoma, multiple myeloma, some solid tumours and other haematological conditions such as myelodysplasia, aplastic anaemia, thalassemia and immune disorders.

The Australasian Bone Marrow Transplant Recipient Registry (ABMTRR) was established in 1992 to record details of haemopoietic stem cell transplants from bone marrow, peripheral blood and more recently cord blood. Originally the Registry recorded data for Australian transplant patients only, but since 1998 the ABMTRR has also included data on New Zealand patients. The ABMTRR operates under the auspices of the Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ). Contributing centres provide registrations of new transplants to the ABMTRR and also information on the progress of previous transplant patients. Currently the database holds information on approximately 26,000 HSCT from 49 centres around Australia and New Zealand.

As well as an Annual Data Summary, the ABMTRR produces regular reports for unrelated donor transplants and cord blood transplants. Data are also provided for research projects and ad hoc requests from clinicians, researchers and government officials. The information may be used for publications in peer reviewed journals, presented at conferences (both local and international) and used by hospital and government departments for administrative and planning purposes.

Since July 2010 the ABMTRR has received some basic operational funding from all Australian Governments, through the Commonwealth Department of Health and Ageing. In October 2012 the ABMTRR office moved to The Kinghorn Cancer Centre in Victoria St, Darlinghurst, sharing a modern open plan office with research and clinical trials staff from St Vincent's Hospital Haematology and Oncology and the Garvan Institute of Medical Research.

In 2013 the new ABMTRR database became available online: ASTRO (Australasian Stem cell Transplants Online). Online availability will streamline the data collection and management processes and allow the contributing centres to access and analyse their own data. There are plans to further enhance the reporting and benchmarking capabilities of the database, and also to develop functionality to enable this system to be used for collaborative research projects.

Arrow has continued its support of the Registry by contributing towards the production and distribution costs of the Annual Data Summary. This document is distributed to more than 400 clinicians and researchers around Australia and New Zealand.


Visit the Australasian Bone Marrow Transplant Recipient Registry (ABMTRR) website.